Your Global Leader in Stem Cell Market Research
BALDWIN PARK, Calif., Jan. 3, 2019 — StemCyte is pleased to announce that the U.S. Food and Drug Administration (FDA), on December 14, 2018, approved its Phase II Investigational New Drug (IND) application for Allogeneic Human Leukocyte Antigen (HLA)-Matched Umbilical Cord Blood Mononuclear Stem Cells (UCBMNC) (MC001) for the treatment of spinal cord injury. [Read more…]
December 21, 2018, New York, NY — Americord Registry, LLC, a leading cord blood, cord tissue, and placental tissue bank, announced today the launch of its new website. The layout and functionality have been optimized for an improved user-experience that better serves Americord’s customers and individuals seeking more education about stem cell banking services. [Read more…]
The American Academy of Stem Cell Physicians (AAOSCP) is hosting an upcoming Conference, Cadaver and Live Workshop on January 26-27, 2019, at the Hyatt Regency in Miami, Florida. The event will feature two days of interactive workshops with small participant-to-instructor ratios with a curriculum focused on regenerative medicine (RM) techniques. The training activities will run from 9am to 5pm both days. [Read more…]
Cord blood banking is defined as the collection and storage of stem cells present within the umbilical cord blood of a newborn for future medical use. Umbilical cord blood is rich in a type of stem cell known as a hematopoietic stem cell (HSC). A large market for the storage of these cells has come into existence over the past 30 years, with public and private cord blood banks now present in all major healthcare markets worldwide. [Read more…]
RANCHO CORDOVA, Calif., Nov. 19, 2018— Cesca Therapeutics Inc. (NASDAQ: KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that its device subsidiary, ThermoGenesis® Corp., has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its proprietary AXP® II AutoXpress® Platform (AXP II) for clinical blood banking.
The AXP II, in combination with the Company’s companion, single-use, cell separation set provides automated, rapid and reliable harvest of stem and progenitor cells from collected units of umbilical cord blood in a “functionally-closed” sterile system. [Read more…]
